comprehensive -WSS

comprehensive

author：explore 2025-08-12 11:28:24 - browse：9

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

Paul Marchetti, the head of insurer Elevance Health’s pharmacy benefit manager, has left the company amid a wave of consumer complaints about patients receiving incorrect medicines or being unable to get their prescriptions filled.

Elevance did not confirm Marchetti’s departure as the president of CarelonRx, but according to his Linkedin profile, he left the company in May.

Elevance, the second-largest commercial health insurer in the country by market share, uses its CarelonRx subsidiary to manage its pharmacy business. In online complaints, CarelonRx customers point toward January 1 as the date when issues with obtaining their prescriptions from the company began. The reported problems include safety issues like receiving other people’s medications or receiving medications they discontinued years ago.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Adopting new red light myopia treatments may be short

focus

WSS

Unique patient identifier: Experts argue the benefits, pitfalls

Roche subsidiary Foundation Medicine opens new headquarters

Gene therapy for Afghan refugees’ infant will be fully covered

Global cancer cases to surge 77% by 2050, WHO report says

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Eliminate the waiting period for sterilization covered by Medicaid

hotspot

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

focus

Guidelines to prevent youth baseball injuries need more muscle

A single Democrat is willing to weaken Medicare negotiation power

The high cost of giving birth even with insurance

Patient advocates debate FDA's accelerated approval process

Heart attack and stroke risk calculators need revising

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

AI gets buy

Novavax promises a turnaround & Lilly roils the obesity market

Readout LOUD: Venture capital, Gilead, and more M&A

Wikipedia

Vyjuvek, a gene therapy for skin wounds, restored vision in one boy

Supreme Court mifepristone arguments center on docs' right to sue

Global cancer cases to surge 77% by 2050, WHO report says

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Readout Newsletter: Merck, Vertex, and Viking updates

entertainment

Wikipedia

focus

knowledge